Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A


#168251

284pages

Renub Research

$ 1600

In Stock


The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in this sector is anticipated to grow despite continuing product recalls and safety controversies, particularly in the Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers segment. Product innovation, together with demographic structure of the world population, will play a pivotal role in the future growth of the market. Additionally, developing healthcare sector and advanced infrastructure along with infusion of new professional skills and expertise in emerging economies continue to propel long-term growth opportunities for manufacturers operating in the market.

Renub Research study titled “Global Cardiac Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A” provides a comprehensive assessment of the fast-evolving, high-growth global cardiac implant market. This 284 page report with 258 Figures and 24 Tables studies the Global Cardiac Implant Device Market. This report contains 24 chapters and has been bifurcate into 10 segments.

i) Worldwide Cardiac Implants Device Analysis (Chapter 2)
ii) Implantable Cardioverter Defibrillators (ICD) (Chapter 3 to 5)
iii) Implantable Cardiac Pacemakers (ICP) (Chapter 6 to 8)
iv) Heart Valve (Chapter 9 to 11)
v) Coronary Stent (Chapter 12 to 15)
vi) Perpheral Stent (Chapter 16 to 17)
vii) Ventricular Assist Device (Chapter 18 to 20)
viii) Cardiac Implants Devices Clinical Trial Statement (Chapter 21)
ix) Merger & Acquisitions (Chapter 22)
x) Growth Drivers & Challenges (Chapter 22 to 24)

All the above segments have been further sub divided into

a) Market & Forecast (2008 - 2017)
b) Sales Unit & Forecast (By Volume) (2008 - 2017)
c) Market Share & Forecast (2008 - 2017)
d) Companies Market Share & Forecast(2008 - 2017)
e) Companies Revenue & Forecast (2008 - 2017)
f) Clinical Trial Statement
g) Merger & Acquisition
h) Growth Driver & Challenges

The Following 24 Chapters Contains

  • First chapter is Executive Summary.
  • Second chapter contains worldwide cardiac implants device market, market share & forecast (2010 – 2017).
  • Third to Fifth chapter contains implantable cardioverter defibrillators (ICD) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008 – 2017).
  • Sixth to Eighth chapter contains implantable cardiac pacemakers (ICP) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008 – 2017).
  • Ninth to Eleventh chapter contains heart valve (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2009-2017).
  • Twelfth to Fifteenth chapter contains coronary stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2008-2017).
  • Sixteenth to Seventeenth chapter contains peripheral stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2010-2017).
  • Eighteenth to nineteenth chapter contains ventricular assist device (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies’ revenue & forecast) (2010-2017).
  • Twentieth to Twenty Three chapters contains clinical trial statement, merger & acquisition, growth driver & challenges.